JB Pharma to Acquire the Entire Razel (Rosuvastatin) Franchise for Rs. 314 Crores
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country JB Pharma, one of the fastest…
JB Pharma Reduces Price of AZMARDA (Sacubitril-Valsartan®) by Nearly 50%
JB Chemicals & Pharmaceuticals Ltd (JB Pharma), one of the fastest-growing pharmaceutical companies in India, announced a substantial price decrease of approximately 50% for the critical heart failure drug “Azmarda”. Azmarda, which contains the patented molecule Saccubutril-Valsartan® is indicated for…
JB Pharma Announces USFDA Approval for its Generic Venlafaxine Extended-Release Tablets
JB Pharma, one of the fastest growing pharmaceutical companies in India, today, has announced that it has received final approval from USFDA for its Abbreviated New Drug Application (ANDA), Venlafaxine Extended-Release Tablets 37.5 mg, 75 mg, 150 mg and 225…
JB Pharma Records Revenue Growth of 30% to INR 785 Crores in Q1FY23
JB Pharma, one of the fastest growing pharmaceutical companies in India, announced its financial results for the first quarter ended 30th June, 2022. For the first quarter ended 30th June 2022, the Company recorded revenue of INR 785 crores as…
